What market is AIM?

The Alternative Investment Market (AIM) is a sub-market of the London Stock Exchange (LSE) that is designed to help smaller companies access capital from the public market.

What is the difference between main market and AIM?

For further information see London Stock Exchange: Main Market….Admission criteria differences – AIM and the Main Market.

AIM Main Market
AIM No prior shareholder approval for most transactions* Main Market Prior shareholder approval required for substantial acquisitions and disposals (Premium Listing only)

Where is the AIM market?

London, England
Alternative Investment Market

Type Stock exchange
Location London, England, UK
Founded 19 June 1995
Owner London Stock Exchange Group
Key people Marcus Stuttard Head of UK Primary Markets and AIM

How does the AIM market work?

AIM shares offer investors a number of ways to take advantage of government-sponsored tax reliefs including Inheritance Tax relief, Capital Gains Tax relief and various other forms of loss relief on shares that qualify for the Enterprise Investment Scheme (EIS) or which are invested in through a Venture Capital Trust ( …

How do I buy shares on AIM?

Steps to trading and investing in AIM shares:

  1. Decide whether you want to trade or invest in AIM shares.
  2. Create an account or log in and go to our platform.
  3. Identify your opportunity.
  4. Take steps to manage your risk.
  5. Open and monitor your position.

Is AIM a UK regulated market?

AIM operates as a multilateral trading facility but is not a regulated market. AIM is a prescribed market and is also designated as a SME growth market.

How do you trade on AIM?

How do I switch from AIM to Main market?

To transfer to the Main Market, an AIM company must:

  1. be eligible for listing on the Official List.
  2. be eligible to be admitted to the Main Market.
  3. produce a prospectus that has been vetted and approved by the FCA.
  4. if seeking a premium listing, appoint a sponsor, and.
  5. cancel its admission to AIM.

Is the AIM market regulated?

How do I trade on AIM?

Is AIM a good buy?

The 3 analysts offering 12-month price forecasts for AIM ImmunoTech Inc have a median target of 6.50, with a high estimate of 7.50 and a low estimate of 3.00. The median estimate represents a +606.44% increase from the last price of 0.92.